Drug intelligence / Profile preview

Tapectam

Development stage
Phase 4
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous
01

Overview

Tapectam is a combination antibiotic product marketed in Colombia, consisting of piperacillin, a broad-spectrum penicillin-class antibiotic, and tazobactam, a beta-lactamase inhibitor. Piperacillin works by binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, thereby inhibiting the third and last stage of bacterial cell wall synthesis. Tazobactam is a penicillanic acid sulfone derivative that functions as a suicide inhibitor of many beta-lactamases, which are enzymes produced by bacteria to confer resistance to beta-lactam antibiotics. By inhibiting these enzymes, tazobactam protects piperacillin from degradation and extends its spectrum of activity to include many beta-lactamase-producing bacteria. Tapectam is indicated for the treatment of severe systemic and/or local bacterial infections, including nosocomial pneumonia, ventilator-associated pneumonia, complicated intra-abdominal infections, and skin and soft tissue infections in adults and pediatric patients.

Brand names
TapectamZosynTazocinPiperacillin/Tazobactam Vitalis
Other names
piperacillin + tazobactampiperacillin sodium + tazobactam sodium
02

Targets

PBP (Penicillin-binding protein family)β-lactamase

Beyond the preview

Go deeper on Tapectam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tapectam.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call